Weil Company, Inc. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
Weil Company, Inc. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2019$120,000,000
+47330.8%
2,820
-55.4%
0.09%
-56.6%
Q2 2019$253,000
-4.2%
6,3200.0%0.20%
-7.2%
Q1 2019$264,000
+9.5%
6,3200.0%0.22%
+1.4%
Q4 2018$241,000
-5.1%
6,3200.0%0.22%
+3.8%
Q3 2018$254,000
-0.4%
6,3200.0%0.21%
-2.8%
Q2 2018$255,0006,3200.22%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2019
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders